Patient's selection for lung transplantation, and the management of patients on the time period during the waiting list;A betegek kiválasztása tüdotranszplantációra és kezelésük a várólistán töltött ido alatt

Orvosi Hetilap

Volumn 147, Issue 43, 2006, Pages 2069-2074

  Csánky, Eszter ^a,b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b NONE   (Hungary)

Author keywords

Investigation; Lung transplantation; Timing of referral; Waiting list

Indexed keywords

ADULT; ARTICLE; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; COR PULMONALE; CYSTIC FIBROSIS; DAILY LIFE ACTIVITY; HOSPITAL ADMISSION; HUMAN; LUNG FIBROSIS; LUNG INSUFFICIENCY; LUNG TRANSPLANTATION; MORTALITY; PATIENT REFERRAL; PATIENT SELECTION; PERSONAL EXPERIENCE; PREOPERATIVE PERIOD; PULMONARY HYPERTENSION; RESPIRATORY FAILURE; RESPIRATORY TRACT DISEASE; SURVIVAL TIME; TREATMENT INDICATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG CONTRAINDICATION; FEMALE; HOSPITALIZATION; LUNG DISEASE; MALE; MIDDLE AGED;

ADULT; CYSTIC FIBROSIS; FEMALE; HUMANS; HYPERTENSION, PULMONARY; LUNG DISEASES; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT SELECTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY FIBROSIS; SEVERITY OF ILLNESS INDEX; WAITING LISTS;

EID: 34248576424     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Amoroso, P., Wilson, S. R., Moxham, J. és mtsa: Acute effects of inhaled salbutamol on the metabolic rate of normal subjects. Thorax, 1993, 43, 882-888.
2. Bjoraker, J. A., Ryu, J. H., Edwin, M. K. és mtsai: Prognostic significance of hystopathologic subsets in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med., 1998, 157, 199-203.
3. Chaparro, C., Maurer, J., Gautierrez, C. és mtsai: Infection with Burkholderia cepacia in cystic fibrosis outcome following lung transplantation. Am. J. Respir. Crit. Care Med., 2001, 163, 43-48.
4. Csánky E., Szabó P., Vaskó A. és mtsai: Végstádiumú tüdobetegségben szenvedo betegek kezelése. Áttekintés a tüdotranszplantációról négy eset kapcsán. Orv. Hetil., 2003, 44, 691-701.
5. Csiszér E., Zsiray M., Jaksch P. és mtsa: Tüdotranszplantáción átesett betegek gondozása során szerzett tapasztalataink. Medicina Thoracalis, 2003, 56, 201-207.
6. Dalton, M. L.: The first lung transplantation. Ann. Thorac. Surg., 1995, 60, 1437-1438.
7. Dash, A., Argawal, A., Venkat, N. és mtsai: Effect of oral theophylline on resting energy expediture in normal volunteers. Thorax, 1994, 49, 1116-1120.
8. De Meester, J., Smits, J., M. Persijn, G. G. és mtsa: Lung transplant waiting list: differential outcome of type of end-stage lung disease, one year after registration. J. Heart Lung Transplant., 1999, 18, 563-571.
9. Egan, J. J.: The management of patients awating lung transplantation. Eur. Respir. Monograph, Vol. 8. Lung transplantation. Szerk.: Boe, J., Estenne, M., Weder, W. Eur. Respir. Society. Journal Ltd., 2003, Sheffield UK. 16-30 old.
10. Gammie, J. S., Pham, S. M., Colson, Y. L. és mtsai: Influence of panel-reactive antibody on survival and rejection after lung transplantation. J. Heart Lung Transplant., 1997, 16, 408-415.
11. Gary, G., Zamora, M. R., Tuder, R. és mtsai: Lung transplantaton: indications, donor and recipient selection, and imaging of complications. Radiographics, 1996, 16, 355-367.
12. Geertsma, A., Ten, Vergert, E. M., Bonsel, G. J. és mtsai: Does lung transplantation prolong life? A comparison of survival with and without transplantation. J. Heart Lung Transplant., 1998, 17, 511-516.
13. Green, I.: Institutional and patient criteria for heart-lung transplantation. Health Technol. Assess., Rockvell, 1994, 1, 1-19.
14. Hosenpud, J. D., Edwards, E. B., Lin, H. M. és mtsa: Influence of HLA matching on thoracic transplant outcomes. An analysis from the UNOS/ISHLT Thoracic Registry. Circulation, 1996, 94, 170-174.
15. Kadikar, A., Maurer, J., Kesten, S.: The six-minute walk test: a guide to assessment for lung transplantation. J. Heart Lung Transplant., 1997, 16, 313-319.
16. Keck, B. M., White, R., Breen, T. J. és mtsai: Thoracic organ transplants in the United States: a report from the UNOS/ISHLT Scientific Registry for Organ Transplants. United Network for Organ Sharing. Internatonal Society for Heart and Lung Transplantation. Clin. Transpl., 1994, 37-46.
17. Kerem, E., Reisman, J., Corey, M. és mtsai: Prediction of mortality in patients with cystic fibrosis. N. Engl. J. Med., 1992, 326, 187-191.
18. Knopp, C., Haverich, A., Fischer, S.: Immunsuppressive therapy after human lung taransplantation. Eur. Respir. Monograph, Vol. 8. Lung transplantation. Szerk.: Boe, J., Estenne, M., Weder, W. 105-129 old.
19. Kurland, G.: Pediatric lung transplantation: indications and contraindications. Semin. Thorac. Cardiovasc. Surg., 1996, 8, 277-285.
20. Maurer, J. R., Frost, A. E., Glanville, R. és mtsai: International guidelines for the selection of lung transplant candidates. Am. J. Respir. Crit. Care Med., 1998, 158, 335-339.
21. Maurer. J. R., Frost, A. E., Estenne, M. és mtsai: International guidelines for the selection of lung transplant candidates. The international Society for Heart and Lung Transplantation, the American Thoracic Society of Transplant Physicians the European Respiratory Society. J. Heart Lung Transplant., 1998, 17, 703-709.
22. Novick, R. J., Stitt, L., Schafers H. J. és mtsai: Pulmonary retransplantation: does the indication for operation influence postoperative lung function? J. Thorac. Cardiovasc. Surg., 1996, 112, 1504-1513; discussion 1513-1514.
23. Rosenbluth, B. D., Wilson, K., Ferkol, T. és mtsa: Lung function decline in cystic fibrosis patients and timing for lung transplantation referral. Chest, 2004, 126, 412-419.
24. Schafers, H. J., Wagner, T. O. Demertzis, S. és mtsai: Preoperative corticosteroids. A contraindication to lung transplantation? Chest, 1992, 102, 1522-1525.
25. Schols, A. M. W. J., Fredrix, E. W. H. M., Soeters, P. B. és mtsai: Resting energy expediture in patients with chronic obstructive pulmonary disease Am. J. Clin. Nutr., 1991, 54, 983-987.
26. Shane, E., Papadopoulos, A., Staron, R. B. és mtsai: Bone loss and fracture after lung transplantation. Transplantation, 1999, 68, 220-227.
27. Sharples, L., Hathaway, T., Dennis, C. és mtsai: Prognosis of patients with cystic fibrosis awaiting heart and lung transplantation. J. Heart Lung Transplant. 1993, 12, 669-674.
28. Wilson, D. O., Rogers, R. M., Wright, E. C. és mtsa: Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. Am. Rev. Respir. Dis., 1989, 139, 1435-1438.
29. Zsiray M., Szabó Zs.: Betegek kiválasztása és az iddozítés kérdése tüdotransz-plantációban. Medicina Thoracalis, 2004, 57, 92-97.
30. Zsiray M., Márczi V., Csanádi K. és mtsa: Tüdotranszplantáció idiopatiás tüdofibrózisban. Medicina Thoracalis, 1998, 51, 158-160.